MERIEUX DEVELOPPEMENT
Mérieux Développement is specialized in Growth and Venture capital transactions in the healthcare and nutrition sectors. We support companies with products or services offering true differentiation and capacity to create substantial value over the long term. Our investment team, based in Europe and North America, brings its expertise and international network to help entrepreneurs disrupt and grasp substantial market opportunities. Mérieux Développement is an affiliate of Institut Mérieux, which employs approximately 17,000 employees worldwide, with consolidated revenues exceeding 2.5 billion Euros in 2017.
MERIEUX DEVELOPPEMENT
Social Links:
Industry:
Health Care Life Science Medical Device Nutrition Pharmaceutical Venture Capital
Founded:
2009-01-01
Status:
Active
Contact:
+1 617 679 8000
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Gandi.net DNS
Similar Organizations
SelfCITOTEST
Medical device to determine the presence of high-risk HPV by self-intake in a simple and intimate way.
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-15 | Omnipharm | Omnipharm acquired by Merieux Developpement | N/A |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-01-24 | SeqOne Genomics | Merieux Developpement investment in Series A - SeqOne Genomics | 20 M EUR |
| 2021-06-03 | Amyl Therapeutics | Merieux Developpement investment in Series A - Amyl Therapeutics | 8.6 M EUR |
| 2020-09-29 | keepMED | Merieux Developpement investment in Series C - keepMED | 13 M EUR |
| 2019-09-24 | Amphivena Therapeutics | Merieux Developpement investment in Series C - Amphivena Therapeutics | 62 M USD |
| 2019-09-10 | Keranova | Merieux Developpement investment in Venture Round - Keranova | 24 M EUR |
| 2019-07-01 | Doc Generici | Merieux Developpement investment in Private Equity Round - Doc Generici | N/A |
| 2019-04-04 | Inscripta | Merieux Developpement investment in Series C - Inscripta | 20 M USD |
| 2018-12-19 | Inscripta | Merieux Developpement investment in Series C - Inscripta | 30 M USD |
| 2018-09-06 | Biobest | Merieux Developpement investment in Private Equity Round - Biobest | 20 M EUR |
| 2018-03-08 | Xeris Pharmaceuticals | Merieux Developpement investment in Series C - Xeris Pharmaceuticals | 10 M USD |